Results 211 to 220 of about 5,293,051 (299)

Triaxial Accelerometry Sensor for Respiratory-Effort Phase Landmark Detection During Sleep: A Cross-Modal Weak Supervision Approach. [PDF]

Bioengineering (Basel)
Lv M, Liao J, Shi Y, Zhang B, Zeng Q, Li Y, Han D.   +6 more
europepmc   +1 more source

APOBEC3 activity and DNA polymerase‐ε deficiency are associated with distinct IDH1 R132 hotspot mutations

Molecular Oncology, EarlyView.
Isocitrate dehydrogenase 1 (IDH1) mutations are highly recurrent in multiple human cancer types, including cholangiocarcinoma and glioma. IDH1 R132C is the most common IDH1 mutation in cholangiocarcinoma and likely arises from APOBEC3A‐ or APOBEC3B‐mediated deamination.
Kelly E. Butler, Bilal A. Lone, Ecem Unal, A. Rouf Banday   +3 more
wiley   +1 more source

Mobile AI-Assisted Oral Lesion Triage for Community Oral Cancer Screening: Prospective Field Evaluation Study. [PDF]

JMIR Mhealth Uhealth
Liu HY, Huang YC, Chen SW, Wei LY, Chou CY, Lee JJ, Chen SJ, Lee CC.   +7 more
europepmc   +1 more source

Standard Operating Procedures [PDF]

, 2012
openaire   +1 more source

Pullman Standard Insurance Plan 1954

, 2017
Pullman -Standard, Linda Bullen (lbullen)   +1 more
core  

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

Molecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault, Capucine Heraud, Mélissa Correia de Oliveira, Véronique Neaud, Valérie Valesco, Valérie Prouzet‐Mauleon, Béatrice Turcq, Jean‐William Dupuy, Anne‐Aurélie Raymond, Sabrina Croce, Frédéric Saltel, Valérie Lagrée, Violaine Moreau   +12 more
wiley   +1 more source

Integrating ctDNA-based ESR1m monitoring into first-line care for ER+, HER2- advanced breast cancer: a consensus workflow. [PDF]

Oncologist
Abdou Y, Cipriani A, Feinstein T, Haumschild R, Mardones M, Mortimer J, Vail E.   +6 more
europepmc   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

Molecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu, Yubei He, Nikolaus Berndt, Michael Mülleder, Kathrin Textoris‐Taube, Jing Guo, Matthias Stechele, Justus Ramtke, Shraga Nahum Goldberg, Lynn Jeanette Savic   +9 more
wiley   +1 more source